Company Search:
Advanced Search
Sponsored Links
Valneva SE Company Snapshot
Valneva SE operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valneva SE with three other pharmaceutical manufacturers in Europe: Horizon Discovery Group PLC of the United Kingdom (2018 sales of £58.73 million [US$71.71 million] of which 79% was Products), Eczacibasi Ilac Sanayi ve T.A.S. of Turkey (692.09 million Turkish Liras [US$117.88 million] of which 80% was Health), and Moberg Pharma AB (publ) which is based in Sweden (439.04 million Swedish Kronor [US$44.08 million] of which 40% was Kerasal Nail /Nalox).

Sales Analysis. During the year ended December of 2018, sales at Valneva SE were 113.04 million Euro (US$123.94 million). This is an increase of 7.4% versus 2017, when the company's sales were 105.29 million Euro. This was the fifth consecutive year of sales increases at Valneva SE (and since 2013, sales have increased a total of 271%). Sales of Commercialized Vaccines saw an increase of 11.6% in 2018, from 92.91 million Euro to 103.65 million Euro. Not all segments of Valneva SE experienced an increase in sales in 2018: sales of Vaccine Candidates fell 64.9% to 2.63 million Euro. Valneva SE also experienced decreases in sales in Technologies and Services (down 27.8% to 6.75 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Valneva SE
  Stock Performance Chart for Valneva SE
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 2.71
(Figures in Euro)
1 Week -3.7%   13 Weeks -9.7%  
4 Weeks -15.0%   52 Weeks -22.7%  
Valneva SE Key Data:
  Ticker: VLA Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 113,035,000
(Year Ending Jan 2019).
Employees: 456
  Currency: Euro Market Cap: 249,281,396
  Fiscal Yr Ends: December Shares Outstanding: 91,985,755
  Share Type: Actions Ordinaires Closely Held Shares: 15,261,163
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.